retatrutide and liver enzymes STUDY: Novel “Triagonist” Resolved Steatosis in Over 85% of Patients with MASLD Obesity Since January 2026, there have

Realistic Expectations with Topical GHK-Cu Peptide GHK-Cu is nicknamed the "anti-aging peptide," but it's important to manage expectations as it's not an overnight miracle worker

As research evolves, so will our approachbut the core principles of clear communication remain constant

Fabricated Endorsements : Supposed support from Harvard, Oxford, or TV shows like the Today Show is often used

We still dont know why people with diabetes (and obesity) dont lose as much weight compared with obesity without diabetes (as Drucker and I discussed in the companion podcast)

Citations Centers for Disease Control and Prevention